Development of an AIDS vaccine is struggling. Topical treatments aimed at stopping HIV have made little progress. Angela Kashuba, PharmD, believes that antiretroviral drugs are the best hope for halting the spread of AIDS, especially in the developing world. “I … Read more

Angela Kashuba, PharmD, will receive the 2009 Leon I. Goldberg Young Investigator Award from the American Society for Clinical Pharmacology and Therapeutics. The award was established in 1986 to honor a young scientist for accomplishments in the field of clinical … Read more

Two professors from the UNC School of Pharmacy—Amanda Corbett and Angela Kashuba—have received the Pam Herriott Award from the UNC Center for Infectious Diseases and the UNC Center for AIDS Research in recognition of their contributions in the fight against … Read more

Angela D. M. Kashuba, PharmD, has been awarded a $1.7 million contract from Boehringer Ingelheim to study the drug-interaction potential of tipranavir, a new HIV protease inhibitor. Protease is an enzyme that HIV needs in order to make new viruses. When protease … Read more

Angela Kashuba, associate professor, has been awarded $1.8 million to evaluate the drug interaction potential of a new HIV protease inhibitor. Bruce Canaday, clinical professor, was installed on March 20 as the 2006-2007 APhA president. Jo Ellen Rodgers, clinical assistant professor, is president-elect, … Read more

A manuscript by associate professor Angela Kashuba has been selected by the Society of Infectious Diseases Pharmacists as “Paper of the Year.” The manuscript is entitled “Combining fosamprenavir with lopinavir/ritonavir substantially reduces amprenavir and lopinavir exposure: ACTG protocol A5143 results”. … Read more

The Cellular Metabolism and Transport Core in the School of Pharmacy has begun operations. This service center has been developed to provide fresh mouse, rat, and human hepatocytes to campus investigators at cost-recovery rates much less than commercial vendors. Other … Read more